跳至主要内容
临床试验/EUCTR2015-002667-42-NL
EUCTR2015-002667-42-NL进行中(未招募)不适用

Sedation with propofol TCI during ERCP: Is the combination with esketamine more effective and safer than with alfentanil (SPEKA): A randomized controlled multicentre trial - SPEKA

AMC0 个研究点开始时间: 2015年9月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
AMC

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • The patients must comply with the following criteria in order to be eligible to participate in this clinical study:
  • Age range = 18 years
  • ASA classification I – III
  • Planned ERCP procedure
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 66

排除标准

  • Patient will be excluded if the following criteria are applicable:
  • Age range < 18 years
  • ASA classification IV and V
  • Allergic reaction to planned medication in the patients’ medical history
  • Unregulated hypertension
  • History of malignant hypertension
  • Significant ischaemic heart disease
  • Mentally disordered
  • History of psychological problems or psychiatric disease
  • Use of drugs that affect the central nervous system
  • Substance abuse
  • Chronic pain
  • Seizure disorders
  • Increased intracranial pressure

研究者

发起方
AMC

相似试验